HGENQ — Humanigen Balance Sheet
0.000.00%
- $0.00m
- -$3.10m
- $2.51m
Annual balance sheet for Humanigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.814 | 0.143 | 67.7 | 70 | 10.2 |
Prepaid Expenses | |||||
Total Current Assets | 1.3 | 0.452 | 68.2 | 71 | 11.1 |
Net Property, Plant And Equipment | 0 | — | — | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1.37 | 0.523 | 68.3 | 71.1 | 11.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.26 | 13.6 | 20.4 | 68.7 | 56.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.48 | 14.8 | 22.8 | 94.7 | 58 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -8.11 | -14.3 | 45.5 | -23.7 | -46.8 |
Total Liabilities & Shareholders' Equity | 1.37 | 0.523 | 68.3 | 71.1 | 11.2 |
Total Common Shares Outstanding |